BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6390258)

  • 1. [Blood coagulation changes and pathogenesis of diabetic retinopathy. Recent advances].
    Porta M; Nuzzi R; Passera P
    Minerva Med; 1984 Oct; 75(41):2407-20. PubMed ID: 6390258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC; Passa P; Canivet J
    Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, endothelium, and coagulation in sepsis.
    Schouten M; Wiersinga WJ; Levi M; van der Poll T
    J Leukoc Biol; 2008 Mar; 83(3):536-45. PubMed ID: 18032692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
    Blann AD; Lip GY
    Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of factor VIII in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM; De Pablo Dávila F; Sánchez Martin S; Alberca Silva I
    Rev Clin Esp; 1980 Feb; 156(3):193-6. PubMed ID: 6966066
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress of research on pathogenesis and medical treatment of diabetic retinopathy].
    Geng S; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):76-81. PubMed ID: 18510248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet abnormalities as related to diabetic retinopathy (with special reference to platelet shape change).
    Porta M; O'Brien ME; Kohner EM
    Horm Metab Res Suppl; 1981; 11():50-4. PubMed ID: 6797912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.
    Rao AK; Goldberg RE; Walsh PN
    J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations].
    Mikhaĭlova NA; Tartakovskaia AI
    Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent advances in the studies of genetic polymorphisms in diabetic retinopathy].
    Wang N; Xu X
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):563-6. PubMed ID: 16857146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
    Naveh-Floman N; Moisseiev J
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium dysfunction markers in patients with diabetic retinopathy.
    Siemianowicz K; Francuz T; Gminski J; Telega A; Syzdól M
    Int J Mol Med; 2005 Mar; 15(3):459-62. PubMed ID: 15702238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
    Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
    Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet adhesion.
    Packham MA; Mustard JF
    Prog Hemost Thromb; 1984; 7():211-88. PubMed ID: 6397767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.